Medicine & Life Sciences
Mastocytosis
100%
Systemic Mastocytosis
52%
N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide
34%
Core Binding Factors
28%
tanespimycin
27%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
25%
Ligands
25%
Dasatinib
24%
Neoplastic Processes
23%
Stem Cell Factor
21%
Gastrointestinal Stromal Tumors
21%
Germ Cell and Embryonal Neoplasms
21%
Imatinib Mesylate
20%
Receptor Protein-Tyrosine Kinases
19%
Sirolimus
19%
Growth and Development
18%
Acute Myeloid Leukemia
17%
Drug Resistance
16%
Protein-Tyrosine Kinases
16%
Cell Differentiation
14%
Phosphotransferases
13%
Carcinogenesis
13%
Therapeutics
11%
Neoplasms
5%
Chemical Compounds
Nilotinib
62%
Disorder
61%
Imatinib
53%
Tyrosine Kinase Inhibitor
50%
Phosphotransferase Inhibitor
45%
Tyrosine
32%
Molecule
24%